FdaApplication
ANDA 218532
Identifiers
- fda_app_no: ANDA218532
Properties
| Property | Value |
|---|---|
| applicant_name | TORRENT PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2025-12-15 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NILOTINIB | NILOTINIB | 200MG | CAPSULE |
| NILOTINIB HYDROCHLORIDE | NILOTINIB HYDROCHLORIDE | EQ 200MG BASE | CAPSULE;ORAL |
| NILOTINIB HYDROCHLORIDE | NILOTINIB HYDROCHLORIDE | EQ 150MG BASE | CAPSULE;ORAL |
3 products